BIO
Daniela Martinez
Associate Director, Global Trade Compliance
ポートフォリオの最適化やレギュラトリー戦略から、フェーズ Ⅰ~フェーズ Ⅳ、市場参入計画など、開発全体を通じたエンドツーエンドのソリューションをご紹介します。
Our team optimizes your portfolio utilizing integrated expert clinical, regulatory, and market access strategies, enabling earlier and more informed risk-reward decisions.
Our multi-disciplinary early phase approach accelerates the path to proof of concept by integrating diverse expertise to optimize study design, generate robust clinical evidence, and reduce gaps between development phases.
We deliver whole-study solutions with integrated strategies that ensure safety, data integrity, and regulatory compliance. We design patient-informed protocols that remove participation barriers, accelerate enrollment, and increase the likelihood of successful drug launches.
Our team of former regulators and HTA professionals provide tailored regulatory, compliance, and market access strategies across specialized therapeutic areas, creating customized pathways to maximize global market reach throughout your product's lifecycle.
We enhance your product's value story through post-approval studies and holistic lifecycle management services that satisfy regulators and payers while building stakeholder trust and maximizing your drug's market impact throughout its entire lifecycle.
ParexelAI leverages our full suite of AI capabilities to deliver with greater speed, quality, and efficiency.

ParexelAI
ParexelAIは、パレクセルのオペレーションに関する豊富な知見と最先端のAI技術を融合し、患者さんへ治療を届けるまでのプロセスを加速する独自のAI活用型の臨床開発ソリューションです。
革新的な試験デザイン、最先端の臨床および規制に関する専門知識、グローバルな視野、そして患者さんの生活を変えることへの情熱を融合させ、治療領域全般にわたる弊社の専門知識をご活用ください。
Our team delivers high-quality clinical trials through forward-thinking medical expertise across multiple indications by combining strategic insight with operational excellence to support programs of all sizes.
Discover our inflammation and immunology CRO services. We bring agile support and a unique MOA-driven model to inflammation and immunology.
Parexel is a leading Oncology CRO with more than 80 ex-agency regulators and nearly 2,500 sites globally. Learn more about our oncology indications.
弊社の専門家が業界の最前線に立ち、変化を先取りするお手伝いをします。
弊社は世界最大級のCROの1つであり、With Heart™を信念とした患者さんへの取り組みによって、Life (生命・生活)を変える医薬品の市場投入を加速させています。弊社がどのような会社で、何を行い、何を信条としているのかをご覧ください。
ポートフォリオの最適化やレギュラトリー戦略から、フェーズ Ⅰ~フェーズ Ⅳ、市場参入計画など、開発全体を通じたエンドツーエンドのソリューションをご紹介します。
Our team optimizes your portfolio utilizing integrated expert clinical, regulatory, and market access strategies, enabling earlier and more informed risk-reward decisions.
Our multi-disciplinary early phase approach accelerates the path to proof of concept by integrating diverse expertise to optimize study design, generate robust clinical evidence, and reduce gaps between development phases.
We deliver whole-study solutions with integrated strategies that ensure safety, data integrity, and regulatory compliance. We design patient-informed protocols that remove participation barriers, accelerate enrollment, and increase the likelihood of successful drug launches.
Our team of former regulators and HTA professionals provide tailored regulatory, compliance, and market access strategies across specialized therapeutic areas, creating customized pathways to maximize global market reach throughout your product's lifecycle.
We enhance your product's value story through post-approval studies and holistic lifecycle management services that satisfy regulators and payers while building stakeholder trust and maximizing your drug's market impact throughout its entire lifecycle.
ParexelAI leverages our full suite of AI capabilities to deliver with greater speed, quality, and efficiency.

ParexelAI
ParexelAIは、パレクセルのオペレーションに関する豊富な知見と最先端のAI技術を融合し、患者さんへ治療を届けるまでのプロセスを加速する独自のAI活用型の臨床開発ソリューションです。
革新的な試験デザイン、最先端の臨床および規制に関する専門知識、グローバルな視野、そして患者さんの生活を変えることへの情熱を融合させ、治療領域全般にわたる弊社の専門知識をご活用ください。
Our team delivers high-quality clinical trials through forward-thinking medical expertise across multiple indications by combining strategic insight with operational excellence to support programs of all sizes.
Discover our inflammation and immunology CRO services. We bring agile support and a unique MOA-driven model to inflammation and immunology.
Parexel is a leading Oncology CRO with more than 80 ex-agency regulators and nearly 2,500 sites globally. Learn more about our oncology indications.
弊社の専門家が業界の最前線に立ち、変化を先取りするお手伝いをします。
弊社は世界最大級のCROの1つであり、With Heart™を信念とした患者さんへの取り組みによって、Life (生命・生活)を変える医薬品の市場投入を加速させています。弊社がどのような会社で、何を行い、何を信条としているのかをご覧ください。
BIO
Associate Director, Global Trade Compliance
Daniela Martinez is the Associate Director and Global Head for Global Trade Compliance (GTC), leading a team of 24 employees who deliver global trade compliance support for clinical trials across APAC, Americas, EU and EMEA's regions to bring supplies and drugs to patients worldwide.
Work Experience
Daniela has been with Parexel for over 12 years. Her extensive import and Export experience allow her to cover several roles like acting as Functional leader, develop import/export logistics strategies and risk management plans, as well as Providing Consultancy to ensure international shipments compliance.
Before starting her Parexel career, Daniela worked as an International Commerce Executive for Mexican Customs Authorities at the “Servicio de Administración Tributaria” (SAT) participating actively at customs houses, managing passengers, documents and shipments clearance, developing risk management analysis, inspections, Gamma’s and X Rays testing and also customs legal assessment.
Education
Daniela holds a Bachelor Degree in International Business by Universidad del Valle de México (UVM) and a Master’s degree in International business and Foreign Trade by Universidad de las Americas (UDLA) at Mexico City, along with several diplomas and specializations related to International Foreign Trade and Customs.